Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells

作者: R. C. Rietbroek , P. J. M. van de Vaart , J. Haveman , F. A. Blommaert , A. Geerdink

DOI: 10.1007/BF01212608

关键词:

摘要: The cytotoxicity of cisplatin and cisplatin-DNA adduct formation in vitro vivo is clearly enhanced by hyperthermia. We investigated whether platinum-DNA two promising new third-generation platinum derivatives, lobaplatin [1,2-diamminomethylcyclobutane platinum(II) lactate] oxaliplatin [oxalato-1,2-diaminocyclohexane platinum(II)], are also Cisplatin was used for comparison. SW 1573 cells were incubated with cisplatin, or at different concentrations 1 h 37°, 41° 43°C. reproductive capacity determined cloning experiments. Immunocytochemical detection adducts performed the rabbit antiserum NKI-A59. At 37°C, most cytotoxic, followed lobaplatin. Hyperthermia oxaliplatin. There no further increase 43°C compared to 41°C A observed thermal enhancement higher than oxaliplatin, reverse pattern 41°C. For both drugs, lower cisplatin. feasible all drugs. Adduct a relative 410%, 170% 180%. These results seem confirm that an involved cytotoxicity. warrants investigations.

参考文章(36)
Raymond B. Weiss, Michaele C. Christian, New cisplatin analogues in development. A review. Drugs. ,vol. 46, pp. 360- 377 ,(1993) , 10.2165/00003495-199346030-00003
Jan D. P. van Dijk, Christoph Schneider, Rob van Os, Leo E. C. M. Blank, Dionisio G. Gonzalez, Results of Deep Body Hyperthermia with Large Waveguide Radiators Advances in Experimental Medicine and Biology. ,vol. 267, pp. 315- 319 ,(1990) , 10.1007/978-1-4684-5766-7_31
B. G. J. Floot, P. M. A. B. Terheggen, L. Den Engelse, A. A. M. Hart, R. Dijkman, A. C. Begg, R. Dubbelman, Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients. Cancer Research. ,vol. 48, pp. 5597- 5603 ,(1988)
B. G. J. Floot, J. Y. Emondt, P. M. A. B. Terheggen, L. Den Engelse, R. Dijkman, A. C. Begg, P. I. Schrier, Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum. Cancer Research. ,vol. 50, pp. 3556- 3561 ,(1990)
Benjamin Drewinko, Barthel Barlogie, Peter M. Corry, In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Research. ,vol. 40, pp. 1165- 1168 ,(1980)
H I Robins, D Rushing, M Kutz, K D Tutsch, C L Tiggelaar, D Paul, D Spriggs, C Kraemer, W Gillis, C Feierabend, R Z Arzoomanian, W Longo, D Alberti, F d'Oleire, R P Qu, G Wilding, J A Stewart, Phase I clinical trial of melphalan and 41.8°C whole-body hyperthermia in cancer patients Journal of Clinical Oncology. ,vol. 15, pp. 158- 164 ,(1993) , 10.1200/JCO.1997.15.1.158
Frank A. Blommeart, Chris P. Saris, Detection of platinum-DNA adducts by 32P-postlabelling. Nucleic Acids Research. ,vol. 23, pp. 1300- 1306 ,(1995) , 10.1093/NAR/23.8.1300
P. M. A. B. Terheggen, B. G. J. Floot, E. L. M. Lempers, O. van Tellingen, A. C. Begg, L. den Engelse, Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides. Cancer Chemotherapy and Pharmacology. ,vol. 28, pp. 185- 191 ,(1991) , 10.1007/BF00685507
R. Voegeli, W. Schumacher, J. Engel, J. Respondek, P. Hilgard, D-19466, a new cyclobutane-platinum complex with antitumor activity. Journal of Cancer Research and Clinical Oncology. ,vol. 116, pp. 439- 442 ,(1990) , 10.1007/BF01612990